#Cervical

Providence Medical Technology has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CORUS Posterior Cervical Stabilization System 3D-T (CORUS PCSS 3D-T), a next-generation version of its posterior cervical fusion (PCF)…

The country implemented a national vaccination program to prevent the disease in 2007. New data show that in 2021, no women under age 25 were diagnosed with cervical cancer, marking a major milestone

While high income countries may eliminate cervical cancer by 2050, women in other regions are likely to remain at risk, found a recent Lancet study

For the first time, Australia has recorded no new cervical cancer diganoses in women under 25.